Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

TASP-V, a novel and selective NPY Y2 agonist for rhinitis and asthma

March 9, 1999

Nuvance advances to phase II clinical trials for long-term control of asthma

March 3, 1999

HFA-134a-BDP controls asthma at half the dose of traditional inhalers

March 3, 1999

Licensing opportunity from BTG: xanthine oxidase inhibitors for treatment of ARDS

March 3, 1999

PDE4 inhibitors claimed by Byk Gulden for airways disorders

March 3, 1999

PPL's initial results of AAT trial in cystic fibrosis

March 1, 1999

Licensing opportunity from BTG: antiasthmatic compound with a novel mechanism of action

March 1, 1999

Clinical trial shows HP-3 effective in COPD

March 1, 1999

Taiwan university researchers present new ATP-sensitive potassium channel opener

Feb. 25, 1999

Tachykinin antagonists specifically claimed for asthma by Merck

Feb. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...